986TiP - A randomized, double-blind, placebo-controlled multicenter phase 3 trial of niraparib maintenance treatment in patients with advanced ovarian cancer following frontline chemotherapy

Autor: Gonzalez Martin, A., Rojas, L.A., Braly, P.S., Barter, J., O'Malley, D.M., Oza, A.M., Haggerty, A.F., Vulsteke, C., Provencher, D.M., Graybill, W., Li, Y., Malinowska, I.A., Mirza, M.R., Vergote, I., Pothuri, B., Monk, B.J.
Zdroj: In Annals of Oncology September 2017 28 Supplement 5:v351-v351
Databáze: ScienceDirect